Cannabics Pharmaceuticals Obaveze 2024

Cannabics Pharmaceuticals Aktienanalyse

Šta radi Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals Inc. is a global company that specializes in the development of personalized therapies using medical cannabis. The company was founded in Israel in 2010 and is headquartered in Tel Aviv. Since then, the company has become a leading player in the medical cannabis industry and has expanded to the United States and Europe. The company's history began with a groundbreaking discovery by the founder's team, who found a method for isolating cannabinoids from cannabis and discovered that cannabinoids have the potential to kill tumor cells. This discovery became the company's passion and they began to focus on the production of personalized therapies using medical cannabis. Cannabics' business model consists of three main divisions: research and development, manufacturing, and commercial distribution of medical cannabis. The company is able to develop personalized therapies that take into account the specific needs of each patient by following a comprehensive approach that considers the specific needs of each patient. Cannabics' research and development department focuses on the development of new personalized therapies and medical devices that include cannabis components. This includes clinical studies to demonstrate the efficacy and safety of cannabis-based medications. The company also works closely with renowned research and development institutions to leverage the latest research and technology. The manufacturing of medical cannabis is another important division of Cannabics. The company operates as a supplier, producing high-quality, personalized cannabis oil specifically tailored to meet the patient's needs. Cannabics works with various strains and cannabis extracts to ensure that each formulation contributes to symptom relief and is safe and effective. Commercial distribution is the third pillar of Cannabics' business model. The company aims to provide its personalized therapies through pharmacies and direct distribution channels to ensure that they reach patients worldwide. Cannabics offers a variety of products, including personalized doses of medical cannabis oil, specific terpene profiles, capsules, extracts, and orally administered medications. The company also offers cannabis tests that are specifically tailored for profiling cancer cells and enabling specific personalization. In recent years, the company has focused on the development of personalized therapies for the treatment of cancer. One of its notable developments is the "Cannabics SR" platform, which provides personalized treatment options for each individual patient based on their cancer genetics. The platform consists of a diagnostic tool to determine the patient's individual cancer and tumor profile. Based on these analyses, the company then formulates a tailored medical treatment using different cannabinoids. Overall, Cannabics Pharmaceuticals Inc. has become a leading company in the medical cannabis industry. The company places a strong emphasis on research and development to develop personalized therapies for the treatment of cancer and other medical conditions and to distribute them worldwide. Cannabics Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Obaveze у детаљу

Ocenjivanje obaveza kompanije Cannabics Pharmaceuticals

Obaveze kompanije Cannabics Pharmaceuticals obuhvataju finansijske obaveze i dugove prema spoljnim stranama i zainteresovanim licima. One se dele na kratkoročne obaveze koje dospevaju u roku od godinu dana i dugoročne obaveze koje dospevaju tokom dužeg vremenskog perioda. Detaljna ocena ovih obaveza je ključna za procenu finansijske stabilnosti, operativne efikasnosti i dugoročne održivosti kompanije Cannabics Pharmaceuticals.

Upoređivanje godina

Upoređivanjem obaveza kompanije Cannabics Pharmaceuticals iz godine u godinu, investitori mogu identifikovati trendove, pomeranja i anomalije u finansijskom pozicioniranju kompanije. Smanjenje ukupnih obaveza često signalizira finansijsko jačanje, dok povećanje može ukazivati na povećane investicije, akvizicije ili moguće finansijske terete.

Utjecaj na investicije

Ukupne obaveze kompanije Cannabics Pharmaceuticals igraju značajnu ulogu u određivanju leveridža (poluge) i rizik profila kompanije. Investitori i analitičari pažljivo proučavaju ovaj aspekt kako bi procenili sposobnost kompanije da ispuni svoje finansijske obaveze, što utiče na privlačnost investicija i kreditne rejtinge.

Interpretacija fluktuacija obaveza

Promene u strukturi obaveza kompanije Cannabics Pharmaceuticals ukazuju na promene u njenoj finansijskoj upravi i strategiji. Smanjenje obaveza odražava efikasno finansijsko vođenje ili otplatu duga, dok povećanje može ukazivati na širenje, akvizicijske aktivnosti ili na nastajanje operativnih troškova, koji imaju različite posledice za investitore.

Često postavljana pitanja o Cannabics Pharmaceuticals akciji

Koliko iznose obaveze kompanije Cannabics Pharmaceuticals ove godine?

Cannabics Pharmaceuticals je ove godine imao obaveze u iznosu od 2,52 mil. USD.

Koliko su iznosile obaveze kompanije Cannabics Pharmaceuticals u poređenju sa prošlom godinom?

Obaveze kompanije Cannabics Pharmaceuticals su u poređenju sa prošlom godinom porasle/opale za 3,28%.

Koje posledice visoke obaveze imaju za investitore Cannabics Pharmaceuticals?

Visoke obaveze mogu predstavljati rizik za investitore Cannabics Pharmaceuticals jer mogu staviti kompaniju u slabiju finansijsku poziciju i uticati na njenu sposobnost da ispunjava svoje obaveze.

Koje posledice niske obaveze imaju za investitore Cannabics Pharmaceuticals?

Niske obaveze znače da Cannabics Pharmaceuticals raspolaže snažnom finansijskom pozicijom i sposoban je da ispuni svoje obaveze bez prekomernog opterećivanja svojih finansija.

Kako povećanje obaveza od Cannabics Pharmaceuticals utiče na kompaniju?

Povećanje obaveza od Cannabics Pharmaceuticals može dovesti do toga da kompanija ima više obaveza i može se naći u težoj situaciji da ispuni svoje finansijske obaveze.

Kako smanjenje obaveza od Cannabics Pharmaceuticals utiče na preduzeće?

Smanjenje obaveza od Cannabics Pharmaceuticals može dovesti do toga da preduzeće ima manje obaveza i snažniju finansijsku poziciju, što mu može olakšati ispunjavanje svojih finansijskih obaveza.

Koji su neki faktori koji utiču na obaveze kompanije Cannabics Pharmaceuticals?

Neki faktori koji mogu uticati na obaveze kompanije Cannabics Pharmaceuticals uključuju, između ostalog, investicije, akvizicije, operativne troškove i razvoj prihoda.

Zašto je visina obaveza kompanije Cannabics Pharmaceuticals tako važna za investitore?

Obaveze kompanije Cannabics Pharmaceuticals su važne za investitore jer su one indikator finansijske stabilnosti kompanije i pružaju investitorima informacije o tome kako kompanija ispunjava svoje finansijske obaveze.

Koje strateške mere Cannabics Pharmaceuticals može preduzeti kako bi promenio obaveze?

Da bi promenio obaveze, Cannabics Pharmaceuticals između ostalog može preduzeti mere poput smanjenja troškova, povećanja prihoda, prodaje imovine, prikupljanja investicija ili uspostavljanja partnerstava. Važno je da kompanija provede temeljan pregled svoje finansijske situacije kako bi izabrala najbolje strateške mere.

Kolika je dividenda koju isplaćuje Cannabics Pharmaceuticals?

U poslednjih 12 meseci, Cannabics Pharmaceuticals je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Cannabics Pharmaceuticals će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Cannabics Pharmaceuticals?

Dividendski prinos od Cannabics Pharmaceuticals trenutno iznosi .

Kada Cannabics Pharmaceuticals isplaćuje dividendu?

Cannabics Pharmaceuticals isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Cannabics Pharmaceuticals?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Cannabics Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Cannabics Pharmaceuticals od 4. 7. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 4. 7. 2024..

Kada je Cannabics Pharmaceuticals poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 4. 7. 2024..

Kolika je bila dividenda od Cannabics Pharmaceuticals u godini 2023?

U godini 2023 kompanija Cannabics Pharmaceuticals je isplatila 0 USD kao dividende.

U kojoj valuti Cannabics Pharmaceuticals isplaćuje dividendu?

Dividende od Cannabics Pharmaceuticals se isplaćuju u USD.